QNRX · Quoin Pharmaceuticals Ltd. · Exempt Offerings
$3.36
-0.20 (-5.64%)
At close · Nov 19
Return incl. dividend (before tax)
Q4 2023 earnings call transcript
Going-concern doubt
— cleared Nov 5, 2026
The latest filing no longer states the doubt (first flagged Aug 14, 2026).
View the 10-Q filed Nov 5, 2026Market Cap
$16.14M
Shares
4.80M
Volume · Nov 19
11.06K
Avg daily vol (3M)
534.28K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
Key facts
CIK
1671502
CUSIP
74907L409
13F (30d)
24 filings
24 filers
Visit website
Investor relations